Jane Hecker

2.3k total citations
32 papers, 1.6k citations indexed

About

Jane Hecker is a scholar working on Psychiatry and Mental health, Physiology and Molecular Biology. According to data from OpenAlex, Jane Hecker has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 14 papers in Physiology and 8 papers in Molecular Biology. Recurrent topics in Jane Hecker's work include Dementia and Cognitive Impairment Research (15 papers), Alzheimer's disease research and treatments (13 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Jane Hecker is often cited by papers focused on Dementia and Cognitive Impairment Research (15 papers), Alzheimer's disease research and treatments (13 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Jane Hecker collaborates with scholars based in Australia, United States and France. Jane Hecker's co-authors include Serge Gauthier, Alistair Burns, Howard Feldman, Bruno Vellas, Lawrence Friedhoff, Martin N. Rossor, Samantha Rogers, H.‐J. Möller, H Petit and Ponni Subbiah and has published in prestigious journals such as Stroke, Journal of the American Geriatrics Society and Annals of Oncology.

In The Last Decade

Jane Hecker

32 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Hecker Australia 16 795 576 438 377 214 32 1.6k
Sharon L. Rogers United States 6 709 0.9× 679 1.2× 376 0.9× 191 0.5× 213 1.0× 8 1.5k
Elias Schwam United States 18 632 0.8× 597 1.0× 572 1.3× 195 0.5× 282 1.3× 37 2.6k
I. Gergel United States 11 936 1.2× 953 1.7× 385 0.9× 170 0.5× 152 0.7× 28 2.3k
Richard D. Hartman United States 25 544 0.7× 563 1.0× 427 1.0× 202 0.5× 276 1.3× 62 1.9k
Ann Marie Hake United States 27 835 1.1× 242 0.4× 738 1.7× 250 0.7× 282 1.3× 68 2.3k
Ponni Subbiah United States 9 1.0k 1.3× 751 1.3× 425 1.0× 264 0.7× 96 0.4× 18 1.6k
Almudena Areosa Sastre United Kingdom 8 508 0.6× 259 0.4× 409 0.9× 228 0.6× 152 0.7× 9 1.5k
Paul Kershaw United States 11 639 0.8× 699 1.2× 361 0.8× 164 0.4× 198 0.9× 13 1.3k
Rachel Schindler United States 21 808 1.0× 362 0.6× 932 2.1× 414 1.1× 269 1.3× 49 2.2k
Sean Lilienfeld United States 14 1.1k 1.4× 1.2k 2.1× 547 1.2× 568 1.5× 315 1.5× 21 2.5k

Countries citing papers authored by Jane Hecker

Since Specialization
Citations

This map shows the geographic impact of Jane Hecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Hecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Hecker more than expected).

Fields of papers citing papers by Jane Hecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Hecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Hecker. The network helps show where Jane Hecker may publish in the future.

Co-authorship network of co-authors of Jane Hecker

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Hecker. A scholar is included among the top collaborators of Jane Hecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Hecker. Jane Hecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wermke, Martin, Sebastian Ochsenreither, Manik Chatterjee, et al.. (2024). 1001MO Initial safety, pharmacokinetics, and anti-tumor activity data of TCER IMA401, a MAGEA4/8-directed half-life extended TCR bispecific, in phase I dose escalation. Annals of Oncology. 35. S681–S682. 2 indexed citations
2.
McNicholas, Kym, Maxime François, Jianwei Liu, et al.. (2022). Salivary inflammatory biomarkers are predictive of mild cognitive impairment and Alzheimer’s disease in a feasibility study. Frontiers in Aging Neuroscience. 14. 1019296–1019296. 10 indexed citations
3.
François, Maxime, Avinash V. Karpe, Jianwei Liu, et al.. (2022). Multi-Omics, an Integrated Approach to Identify Novel Blood Biomarkers of Alzheimer’s Disease. Metabolites. 12(10). 949–949. 22 indexed citations
4.
François, Maxime, Avinash V. Karpe, Jianwei Liu, et al.. (2021). Salivaomics as a Potential Tool for Predicting Alzheimer’s Disease During the Early Stages of Neurodegeneration. Journal of Alzheimer s Disease. 82(3). 1301–1313. 22 indexed citations
5.
François, Maxime, et al.. (2018). γH2AX is increased in peripheral blood lymphocytes of Alzheimer’s disease patients in the South Australian Neurodegeneration, Nutrition and DNA Damage (SAND) study of aging. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 829-830. 6–18. 16 indexed citations
6.
7.
François, Maxime, Wayne R. Leifert, Jane Hecker, et al.. (2014). Altered cytological parameters in buccal cells from individuals with mild cognitive impairment and Alzheimer's disease. Cytometry Part A. 85(8). 698–708. 34 indexed citations
8.
Dobson‐Stone, Carol, Agnes A. Luty, Elizabeth M. Thompson, et al.. (2013). Frontotemporal dementia–amyotrophic lateral sclerosis syndrome locus on chromosome 16p12.1–q12.2: genetic, clinical and neuropathological analysis. Acta Neuropathologica. 125(4). 523–533. 16 indexed citations
9.
Luty, Agnes A., John B. Kwok, Elizabeth M. Thompson, et al.. (2008). Pedigree with frontotemporal lobar degeneration – motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9. BMC Neurology. 8(1). 32–32. 58 indexed citations
10.
Thomas, Philip, et al.. (2007). Buccal micronucleus cytome biomarkers may be associated with Alzheimer's disease. Mutagenesis. 22(6). 371–379. 85 indexed citations
11.
Feldman, Howard, Serge Gauthier, Jane Hecker, et al.. (2005). Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo‐controlled trial. International Journal of Geriatric Psychiatry. 20(6). 559–569. 92 indexed citations
12.
Hecker, Jane, et al.. (2003). Evaluation of donepezil in Alzheimer's disease ‐Experience from an Australian memory clinic. Australasian Journal on Ageing. 22(3). 146–150. 1 indexed citations
13.
Feldman, Howard, Serge Gauthier, Jane Hecker, et al.. (2003). Efficacy of Donepezil on Maintenance of Activities of Daily Living in Patients with Moderate to Severe Alzheimer's Disease and the Effect on Caregiver Burden. Journal of the American Geriatrics Society. 51(6). 737–744. 160 indexed citations
14.
Gauthier, Serge, Howard Feldman, Jane Hecker, et al.. (2002). Functional, Cognitive and Behavioral Effects of Donepezil in Patients with Moderate Alzheimer's Disease. Current Medical Research and Opinion. 18(6). 347–354. 74 indexed citations
15.
Gauthier, Serge, Howard Feldman, Jane Hecker, et al.. (2002). Efficacy of Donepezil on Behavioral Symptoms in Patients With Moderate to Severe Alzheimer’s Disease. International Psychogeriatrics. 14(4). 389–404. 173 indexed citations
16.
Gauthier, Serge, Howard Feldman, Jane Hecker, et al.. (2000). Effects of donepezil on behaviour and other domains in moderate to severe Alzheimer's disease. European Neuropsychopharmacology. 10. 359–360. 4 indexed citations
17.
Gauthier, Serge, Howard Feldman, Jane Hecker, et al.. (2000). Benefits of donepezil on performance of basic and instrumental activities of daily living in moderate to severe Alzheimer's disease. Neurobiology of Aging. 21. 161–161. 5 indexed citations
18.
Hecker, Jane. (2000). Driving into Danger? Compulsory Driving Licence Cancellation in Alzheimer's Disease. Australasian Journal on Ageing. 19(4). 158–159. 2 indexed citations
19.
Burns, Alistair, Martin N. Rossor, Jane Hecker, et al.. (1999). The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial<sup>1</sup>. Dementia and Geriatric Cognitive Disorders. 10(3). 237–244. 481 indexed citations
20.
Hecker, Jane. (1998). Alzheimer's disease: the advent of effective therapy. Australian and New Zealand Journal of Medicine. 28(6). 765–771. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharon L. Rogers Breakdown of academic impact, for papers by Elias Schwam Breakdown of academic impact, for papers by I. Gergel Breakdown of academic impact, for papers by Richard D. Hartman Breakdown of academic impact, for papers by Ann Marie Hake Breakdown of academic impact, for papers by Ponni Subbiah Breakdown of academic impact, for papers by Almudena Areosa Sastre Breakdown of academic impact, for papers by Paul Kershaw Breakdown of academic impact, for papers by Rachel Schindler Breakdown of academic impact, for papers by Sean Lilienfeld
Rankless by CCL
2026